BioLife Solutions (NASDAQ: BLFS) reported Q2 EPS of ($0.23), $0.02 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $39.5 million versus the consensus estimate of $43.64 million.

GUIDANCE:

BioLife Solutions sees FY2023 revenue of $144-158 million, versus the consensus of $184.1 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.